Literature DB >> 18378565

Does gefitinib shorten lung cancer survival? Chaos redux.

Vicki L Keedy, Carlos L Arteaga, David H Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18378565     DOI： 10.1200/JCO.2008.16.0374

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.

Authors:  Joshua D Palmer; Nicholas G Zaorsky; Matthew Witek; Bo Lu
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expression.

Authors:  Vikas Bhardwaj; Yanai Zhan; Maria Angelica Cortez; Kie Kian Ang; David Molkentine; Anupama Munshi; Uma Raju; Ritsuko Komaki; John V Heymach; James Welsh
Journal:  J Thorac Oncol       Date:  2012-08       Impact factor: 15.609
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.